Abstract

Background: Photodynamic therapy(PDT) is a non-invasive treatment modality for selective destruction of cancer and other diseases.PDT has several potential advantages over surgery and radiotherapy, It requires three elements: a photosensitizer(PS), light and oxygen, Nanoparticles are efficient means to deliver photosensitizers for photodynamic therapy. However, it is largely unknown if Photosan-II can be efficiently delivered by hollow silica nanoparticles (HSNP). We investigated the effects and functional mechanisms of photodynamic therapy (PDT) mediated by a nanocrystallized photosensitizer (Photosan-loaded hollow silica nanoparticles) on the human colon carcinoma cell line HT29.Methods: HT29 cells were treated with nanocrystallized photosensitizer-mediated PDT, and the rate of cell survival and effects on apoptosis or cell necrosis were investigated with tetrazolium (MTT) assays and flow cytometry, respectively. We quantified the variation of Bcl-2 and Bax expression in nude mice transplanted with HT29 cells before and after PDT with quantitative reverse transcription-polymerase chain reaction (qRT-PCR).Results: MTT assays revealed that cell growth was inhibited in an obvious manner, and there was a dramatic decline in the rate of survival (P < 0.05) following PDT; flow cytometry showed predominant induction of apoptosis in PDT-treated cells. qRT-PCR revealed that PDT downregulated Bcl-2 expression with concomitant upregulation of Bax expression in HT29 cells, i.e., the Bcl-2/Bax expression ratio was decreased.Conclusion: PDT mediated by Photosan-loaded hollow silica nanoparticles inhibits the growth of human colon carcinoma HT29 cells with predominant induction of apoptosis. It can also downregulate the Bcl-2/Bax expression ratio, thereby inducing apoptosis in HT29 cells.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.